![](/wp-content/uploads/2019/11/mylan-bd-earnings.png)
$599
Mylan and BD Q3 ’19 Earnings Updates
Mylan and Becton Dickinson hosted their respective Q3 ’19 earnings calls. Of note, Mylan provided a brief update on its insulin development program (in partnership with Biocon). Below, FENIX provides diabetes-related highlights and insights from the calls.